InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Cellmid Investor Presentation 10 Apr 2018 8:57AM $0.430 $0.056 fallen by 86.98%
- CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH 9 Apr 2018 10:04AM $0.450 $0.056 fallen by 87.56%
- CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA 4 Apr 2018 10:15AM $0.450 $0.056 fallen by 87.56%
- Change of Director's Interest Notice-Halasz 29 Mar 2018 9:52AM $0.470 $0.056 fallen by 88.09%
- Initial Director's Interest Notice 26 Mar 2018 10:05AM $0.460 $0.056 fallen by 87.83%
- CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR 26 Mar 2018 9:55AM $0.460 $0.056 fallen by 87.83%
- Change of Director's Interest Notice-Halasz 14 Mar 2018 3:03PM $0.455 $0.056 fallen by 87.69%
- Appendix 4D and Half Year Accounts 22 Feb 2018 9:48AM $0.510 $0.056 fallen by 89.02%
- Change of Director's Interest Notice-Halasz 31 Jan 2018 1:28PM $0.500 $0.056 fallen by 88.80%
- Appendix 4C - quarterly 25 Jan 2018 3:05PM $0.500 $0.056 fallen by 88.80%
- RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS 10 Jan 2018 9:31AM $0.500 $0.056 fallen by 88.80%
- CELLMID QUARTERLY OPERATIONAL UPDATE 9 Jan 2018 11:44AM $0.490 $0.056 fallen by 88.57%
- Change of Director's Interest Notice-Halasz 22 Dec 2017 5:10PM $0.445 $0.056 fallen by 87.42%
- Cleansing Statement & Appendix 3B 19 Dec 2017 1:47PM $0.415 $0.056 fallen by 86.51%
- CELLMID PLACEMENT TO STRATEGIC INVESTOR 15 Dec 2017 4:41PM $0.395 $0.056 fallen by 85.82%
- CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLIS 7 Dec 2017 9:33AM $0.390 $0.056 fallen by 85.64%
- CELLMID CAPITAL STRUCTURE POST CONSOLIDATION 5 Dec 2017 11:08AM $0.375 $0.056 fallen by 85.07%
- YPB: Agreement with Cellmid to access Chinese health market 28 Nov 2017 1:44PM $0.019 $0.056 risen by 194.74%
- CELLMID SIGNS AGREEMENT WITH YPB FOR CHINA MARKET 28 Nov 2017 1:44PM $0.019 $0.056 risen by 194.74%
- CHANGE OF AUDITOR 24 Nov 2017 1:10PM $0.020 $0.056 risen by 180%
- Update - Consolidation/Split - CDY 23 Nov 2017 4:53PM $0.020 $0.056 risen by 180%
- Results of Annual General Meeting 23 Nov 2017 11:33AM $0.020 $0.056 risen by 180%
- AGM Presentation to Shareholders 23 Nov 2017 8:32AM $0.019 $0.056 risen by 194.74%
- Appendix 3B-Unlisted options 16 Nov 2017 1:13PM $0.020 $0.056 risen by 180%
- ASIC Form 484 15 Nov 2017 3:30PM $0.020 $0.056 risen by 180%

251 - 275 of 530 results

Page 11 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.